Sign up to our newsletter Subscribe
Donor Investment Choices: Modeling the Value for Money of Investing in Product Development, Public Private Parnerships as Compared to Other Health Care and Non-Health Care Interventions

Three Challenges to Achieving Better Analysis for Better Decisions: Generalisability, Complexity and Thresholds

The Faces of Regulation: Profit and Price Regulation of the UK Pharmaceutical Industry after the 1998 Competition Act
